NDC Code(s) : 42291-257-90
Packager : AvKARE, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| DutasterideDutasteride CAPSULE | ||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
PRINCIPAL DISPLAY PANEL
AvKARE
NDC
42291-257-90
Dutasteride Capsules
0.5 mg
WARNING: Dutasteride Capsules should not be used by women or children. Women who are or may potentially be pregnant should not use or handle Dutasteride Capsules (see prescribing information). If contact is made with leaking capsule, wash immediately with soap and water.
90 Capsules Rx Only
Pharmacist: Please Dispense with Patient Information Leaflet Provided Separately to Each patient.
Each soft gelatin capsule contains 0.5 mg of dutasteride, USP
Usual Adult Dosage: 0.5 mg once a day. Capsules should be swallowed show and not chewed or opened. See
prescribing information for further dosing information.
Store at 20° to 25°C (59° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room
Temperature].
Dispense in a tight, light-resistant container as defined in the USP.
Do not use if seal under bottle cap is broken or missing.
Manufactured for:
AvKARE, Inc.
Pulaski, TN 38478
Mfg. Rev. 10-2015-01 AV 11/15 (P)
N3 42291 25790 0








